Lundholm et al. found that the NKG2D (also known as KLRK1, killer cell lectin-like receptor K1) ligand-expressing prostate tumor-derived TEX selectively downregulated NKG2D on NK and CD8+ T cells, leading to impaired cytotoxic function in vitro [99]. The gene discussed is KLRK1; the disease is prostate neoplasm.